Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC β-lactamases
- 30 April 2004
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 23 (4) , 398-400
- https://doi.org/10.1016/j.ijantimicag.2003.08.010
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Complexity and Diversity of Klebsiella pneumoniae Strains with Extended-Spectrum β-Lactamases Isolated in 1994 and 1996 at a Teaching Hospital in Durban, South AfricaAntimicrobial Agents and Chemotherapy, 2001
- OXA-17, a Further Extended-Spectrum Variant of OXA-10 β-Lactamase, Isolated from Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1999
- Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from SingaporeThe Lancet, 1999
- β-Lactamases Responsible for Resistance to Expanded-Spectrum Cephalosporins in Klebsiella pneumoniae , Escherichia coli , and Proteus mirabilis Isolates Recovered in South AfricaAntimicrobial Agents and Chemotherapy, 1998
- Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structureAntimicrobial Agents and Chemotherapy, 1995
- beta-Lactamases in laboratory and clinical resistanceClinical Microbiology Reviews, 1995
- Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.Microbiological Reviews, 1993
- Effects of CO2 and pH on inhibition of TEM-1 and other beta-lactamases by penicillanic acid sulfonesAntimicrobial Agents and Chemotherapy, 1992
- A standard numbering scheme for the class A β-lactamasesBiochemical Journal, 1991